Invus Partners, Llc - Net Worth and Insider Trading
Invus Partners, Llc Net Worth
The estimated net worth of Invus Partners, Llc is at least $10 Million dollars as of 2024-09-20. Invus Partners, Llc is the Director, 10% Owner of Lexicon Pharmaceuticals Inc and owns about 5,782,749 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $10 Million. Details can be seen in Invus Partners, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Invus Partners, Llc has not made any transactions after 2022-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Invus Partners, Llc
Invus Partners, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Invus Partners, Llc owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Invus Partners, Llc’s form 4 insider trades.
Insider Ownership Summary of Invus Partners, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2022-08-05 | director & 10 percent owner |
Invus Partners, Llc Latest Holdings Summary
Invus Partners, Llc currently owns a total of 1 stock. Invus Partners, Llc owns 5,782,749 shares of Lexicon Pharmaceuticals Inc (LXRX) as of August 5, 2022, with a value of $10 Million.
Latest Holdings of Invus Partners, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2022-08-05 | 5,782,749 | 1.65 | 9,512,622 |
Holding Weightings of Invus Partners, Llc
Invus Partners, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Invus Partners, Llc has made a total of 2 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 147,390 shares on August 5, 2022, which cost Invus Partners, Llc around $368,475.
Insider Trading History of Invus Partners, Llc
- 1
Invus Partners, Llc Trading Performance
GuruFocus tracks the stock performance after each of Invus Partners, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Invus Partners, Llc is -16.42%. GuruFocus also compares Invus Partners, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Invus Partners, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Invus Partners, Llc's insider trading performs compared to the benchmark.
Performance of Invus Partners, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.29 | | | | | |
| Relative Return to S&P 500(%) | 10.8 | | | | | |
Invus Partners, Llc Ownership Network
Invus Partners, Llc Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Invus Partners, Llc is the director & 10 percent owner of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Invus Partners, Llc made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Invus Partners, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Invus Partners, Llc. You might contact Invus Partners, Llc via mailing address: 750 Lexington Ave, 30th Fl, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
